DSIJ Mindshare

2,200 per cent returns and 52-week high alert: Vijay Kedia gains Rs 23,80,42,000 in this multibagger pharma stock in just one day; reports strong growth in profits!

Shares of the company gained more than 70 per cent in the last six months.

Praveenkumar Yadav 1 16950 Article rating: 4.0

Shares of the company gained more than 70 per cent in the last six months.

Being the top BSE gainer, shares of this pharmaceutical company were locked at the 20 per cent upper circuit! Do you own it?

In such a weak market, its strong price-volume breakout kept the bulls in the small-cap sector busy.

Mandar Wagh 0 812 Article rating: 4.7

In such a weak market, its strong price-volume breakout kept the bulls in the small-cap sector busy. 

RSS
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR